OAMU
PFE icon

Ostrum Asset Management US’s Pfizer PFE Stock Holding History

Ostrum Asset Management US’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-35,602
Closed -$1.47M – 175
2018
Q4 		$1.47M Buy
+35,602
New +$1.48M 0.22% 53

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ostrum Asset Management US's PFE Position: Q1 2019 in Review

Ostrum Asset Management US sold out of Pfizer (PFE) in Q1 2019, closing a stake of 35,602 shares — an estimated $1.47M sold.

Ostrum Asset Management US first reported a position in PFE in Q4 2018 and held it in 1 quarter. The position peaked at $1.47M in Q4 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Ostrum Asset Management US reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
  • Ostrum Asset Management US sold 35,602 Pfizer shares in Q1 2019, an estimated $1.47M.
  • Ostrum Asset Management US first reported a position in Pfizer in Q4 2018 and held it in 1 quarter.
  • Ostrum Asset Management US's Pfizer position peaked at $1.47M in Q4 2018.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Ostrum Asset Management US's 13F filing for Q1 2019, filed 15 May 2019.